289 related articles for article (PubMed ID: 27534821)
1. Human leukocyte Antigen-DM polymorphisms in autoimmune diseases.
Alvaro-Benito M; Morrison E; Wieczorek M; Sticht J; Freund C
Open Biol; 2016 Aug; 6(8):. PubMed ID: 27534821
[TBL] [Abstract][Full Text] [Related]
2. Revisiting nonclassical HLA II functions in antigen presentation: Peptide editing and its modulation.
Álvaro-Benito M; Freund C
HLA; 2020 Oct; 96(4):415-429. PubMed ID: 32767512
[TBL] [Abstract][Full Text] [Related]
3. Distinct editing functions of natural HLA-DM allotypes impact antigen presentation and CD4
Álvaro-Benito M; Morrison E; Ebner F; Abualrous ET; Urbicht M; Wieczorek M; Freund C
Cell Mol Immunol; 2020 Feb; 17(2):133-142. PubMed ID: 30467419
[TBL] [Abstract][Full Text] [Related]
4. HLA-DM catalytically enhances peptide dissociation by sensing peptide-MHC class II interactions throughout the peptide-binding cleft.
Reyes-Vargas E; Barker AP; Zhou Z; He X; Jensen PE
J Biol Chem; 2020 Mar; 295(10):2959-2973. PubMed ID: 31969393
[TBL] [Abstract][Full Text] [Related]
5. HLA-DMA polymorphisms differentially affect MHC class II peptide loading.
Álvaro-Benito M; Wieczorek M; Sticht J; Kipar C; Freund C
J Immunol; 2015 Jan; 194(2):803-16. PubMed ID: 25505276
[TBL] [Abstract][Full Text] [Related]
6. Human Hepatitis B Viral Infection Outcomes Are Linked to Naturally Occurring Variants of
Graves AM; Virdis F; Morrison E; Álvaro-Benito M; Khan AA; Freund C; Golovkina TV; Denzin LK
J Immunol; 2020 Aug; 205(4):923-935. PubMed ID: 32690655
[TBL] [Abstract][Full Text] [Related]
7. Achieving stability through editing and chaperoning: regulation of MHC class II peptide binding and expression.
Busch R; Rinderknecht CH; Roh S; Lee AW; Harding JJ; Burster T; Hornell TM; Mellins ED
Immunol Rev; 2005 Oct; 207():242-60. PubMed ID: 16181341
[TBL] [Abstract][Full Text] [Related]
8. A role for HLA-DO as a co-chaperone of HLA-DM in peptide loading of MHC class II molecules.
Kropshofer H; Vogt AB; Thery C; Armandola EA; Li BC; Moldenhauer G; Amigorena S; Hämmerling GJ
EMBO J; 1998 Jun; 17(11):2971-81. PubMed ID: 9606180
[TBL] [Abstract][Full Text] [Related]
9. HLA-DO acts as a substrate mimic to inhibit HLA-DM by a competitive mechanism.
Guce AI; Mortimer SE; Yoon T; Painter CA; Jiang W; Mellins ED; Stern LJ
Nat Struct Mol Biol; 2013 Jan; 20(1):90-8. PubMed ID: 23222639
[TBL] [Abstract][Full Text] [Related]
10. Targeted regulation of self-peptide presentation prevents type I diabetes in mice without disrupting general immunocompetence.
Yi W; Seth NP; Martillotti T; Wucherpfennig KW; Sant'Angelo DB; Denzin LK
J Clin Invest; 2010 Apr; 120(4):1324-36. PubMed ID: 20200448
[TBL] [Abstract][Full Text] [Related]
11. Peptidomic analysis of type 1 diabetes associated HLA-DQ molecules and the impact of HLA-DM on peptide repertoire editing.
Zhou Z; Reyes-Vargas E; Escobar H; Chang KY; Barker AP; Rockwood AL; Delgado JC; He X; Jensen PE
Eur J Immunol; 2017 Feb; 47(2):314-326. PubMed ID: 27861808
[TBL] [Abstract][Full Text] [Related]
12. Mouse Homologue of Human HLA-DO Does Not Preempt Autoimmunity but Controls Murine Gammaherpesvirus MHV68.
Lee J; Cullum E; Stoltz K; Bachmann N; Strong Z; Millick DD; Denzin LK; Chang A; Tarakanova V; Chervonsky AV; Golovkina T
J Immunol; 2021 Dec; 207(12):2944-2951. PubMed ID: 34810225
[TBL] [Abstract][Full Text] [Related]
13. Human leukocyte antigen-DO regulates surface presentation of human leukocyte antigen class II-restricted antigens on B cell malignancies.
Kremer AN; van der Meijden ED; Honders MW; Pont MJ; Goeman JJ; Falkenburg JH; Griffioen M
Biol Blood Marrow Transplant; 2014 May; 20(5):742-7. PubMed ID: 24530695
[TBL] [Abstract][Full Text] [Related]
14. pH-susceptibility of HLA-DO tunes DO/DM ratios to regulate HLA-DM catalytic activity.
Jiang W; Strohman MJ; Somasundaram S; Ayyangar S; Hou T; Wang N; Mellins ED
Sci Rep; 2015 Nov; 5():17333. PubMed ID: 26610428
[TBL] [Abstract][Full Text] [Related]
15. The MHC Class II Antigen-Processing and Presentation Pathway Is Dysregulated in Type 1 Diabetes.
Gilles A; Hu L; Virdis F; Sant'Angelo DB; Dimitrova N; Hedrick JA; Denzin LK
J Immunol; 2023 Dec; 211(11):1630-1642. PubMed ID: 37811896
[TBL] [Abstract][Full Text] [Related]
16. HLA-DO transduced in human monocyte-derived dendritic cells modulates MHC class II antigen processing.
Bellemare-Pelletier A; Tremblay J; Beaulieu S; Boulassel MR; Routy JP; Massie B; Lapointe R; Thibodeau J
J Leukoc Biol; 2005 Jul; 78(1):95-105. PubMed ID: 15817706
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of HLA-DM Mediated MHC Class II Peptide Loading by HLA-DO Promotes Self Tolerance.
Denzin LK
Front Immunol; 2013 Dec; 4():465. PubMed ID: 24381574
[TBL] [Abstract][Full Text] [Related]
18. Heterodimer HLA-DM Fused with Constant Fragment of the Heavy Chain of the Human Immunoglobulin Accelerates Influenza Hemagglutinin HA306-318 Loading to HLA-DR1.
Mamedov AE; Ponomarenko NA; Belogurov AA; Gabibov AG
Bull Exp Biol Med; 2016 May; 161(1):92-5. PubMed ID: 27265131
[TBL] [Abstract][Full Text] [Related]
19. Editing of the HLA-DR-peptide repertoire by HLA-DM.
Kropshofer H; Vogt AB; Moldenhauer G; Hammer J; Blum JS; Hämmerling GJ
EMBO J; 1996 Nov; 15(22):6144-54. PubMed ID: 8947036
[TBL] [Abstract][Full Text] [Related]
20. HLA-DM Focuses on Conformational Flexibility Around P1 Pocket to Catalyze Peptide Exchange.
Yin L; Stern LJ
Front Immunol; 2013 Oct; 4():336. PubMed ID: 24146666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
